MediPharm Labs Corp. (TSX:LABS)
Canada flag Canada · Delayed Price · Currency is CAD
0.0800
0.00 (0.00%)
May 22, 2026, 9:33 AM EST

MediPharm Labs Balance Sheet

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
9.8710.8111.6917.9824.1534.11
Cash & Short-Term Investments
9.8710.8111.6917.9824.1534.11
Cash Growth
16.85%-7.56%-34.99%-25.53%-29.21%71.30%
Accounts Receivable
6.537.537.515.8712.8816.92
Inventory
8.478.028.719.97.7810.98
Other Current Assets
0.861.115.172.892.553.54
Total Current Assets
25.7327.4733.0836.6393.8665.55
Net Property, Plant & Equipment
17.2617.619.1625.2718.1125.89
Other Intangible Assets
0.630.680.851.030.040.04
Other Long-Term Assets
--0.641-0.88
Total Assets
43.6245.7453.7363.9465.592.36
Accounts Payable
7.689.27.866.757.126.21
Accrued Expenses
0.820.522.31.891.742.55
Short-Term Debt
0.020.20.342.230.60.11
Unearned Revenue
-----0
Total Current Liabilities
8.529.9310.510.869.468.88
Long-Term Debt
--0.050.070.030.1
Other Long-Term Liabilities
-----0.24
Total Long-Term Liabilities
--0.050.070.030.34
Total Liabilities
8.529.9310.5510.939.499.22
Common Stock
201.9201.9201.21200.24191.26190.55
Additional Paid-in Capital
3.553.429.5629.5328.421.91
Accumulated Other Comprehensive Income
-0.11-0.11-0.16-0.04-0.03
Retained Earnings
-170.25-169.38-187.43-176.73-163.65-129.34
Shareholders' Equity
35.135.8143.1853.0156.0183.15
Total Liabilities & Equity
43.6245.7453.7363.9465.592.36
Total Debt
0.020.20.392.30.630.22
Net Cash (Debt)
9.8510.6111.315.6923.5133.89
Net Cash Growth
-7.14%-6.17%-27.95%-33.29%-30.63%2834.55%
Net Cash Per Share
0.020.030.030.040.090.14
Book Value
35.135.8143.1853.0156.0183.15
Book Value Per Share
0.080.090.110.150.200.33
Tangible Book Value
34.4735.1442.3351.9755.9783.1
Tangible Book Value Per Share
0.080.080.100.140.200.33
Updated May 13, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.